NCT07080515

Brief Summary

The goal of this observational study is to engage with multilevel stakeholders to collaboratively and to systematically develop a suite of strategies for implementing breast cancer screening using clinical breast examination (CBE) in the primary health centers of Abuja, Nigeria. The main questions it aims to answer are: What barriers and facilitators exist to conducting screening CBE in Abuja's primary care setting and what implementation strategies would support CBE in primary care clinics? Participants will:

  • Allow observation of study clinic workflows
  • Participate in interviews and focus group discussions regarding screening CBE implementation

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
2mo left

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Sep 2025Jul 2026

First Submitted

Initial submission to the registry

June 30, 2025

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 23, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

November 13, 2025

Status Verified

November 1, 2025

Enrollment Period

7 months

First QC Date

June 30, 2025

Last Update Submit

November 12, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Intervention Domain Characteristics

    Characteristics of routine clinical breast examination itself that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.

    1 year

  • Inner Setting Domain Characteristics

    Characteristics of the primary care clinics that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.

    1 year

  • Outer Setting Domain Characteristics

    Characteristics of both the community surrounding the clinics and the district-wide health system that are potential barriers and facilitators to screening implementation, , emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.

    1 year

  • Individuals Domain Characteristics

    Characteristics of individuals involved in screening that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.

    1 year

  • Implementation Domain Characteristics

    Characteristics of activities and strategies used to implement screening that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.

    1 year

Study Arms (3)

Adopters

Individuals responsible for deciding to institute screening CBE in Abuja's primary care clinics (e.g., policymakers, clinic administrators, nurse managers)

Implementers

Individuals responsible for actually performing the screening CBE in Abuja's primary care clinics (e.g., nurses, doctors, fieldworkers, clerical workers)

Recipients

Individuals eligible for a screening CBE (e.g., women over the age of 40 years from the community surrounding study clinics)

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Focus group participants will consist of three categories: screening CBE "adopter" (e.g., clinic administrators/managers, department of health officials, etc), "implementers" (e.g., nurses, physicians, community health workers), and "recipients" (e.g., women from the community eligible for CBE screening and community breast cancer survivors). All participants will be drawn from the two study clinics in Abuja, Nigeria.

In order to be eligible for inclusion in the focus group discussions held with screening CBE "adopters" and "implementers," an individual must meet all of the following criteria: 1. Be an employee or volunteer working at a participating PHC OR Be an employee or volunteer working at Nigeria's Ministry of Health OR Be an employee or volunteer working with a non-governmental organization that performs breast cancer related activities within the catchment area of a participating PHC 2. Be willing to commit to keeping the content of focus group discussions confidential In order to be eligible for inclusion in the focus group discussions held with screening CBE "recipients," an individual must meet all of the following criteria: 1. Be female 2. Be between the ages of 40 and 65 years 3. Be living within the catchment area of a participating PHC 4. Be willing to commit to keeping the content of focus group discussions confidential

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Institute of Human Virology, Nigeria

Abuja, Nigeria

RECRUITING

Study Officials

  • Daniel O'Neil, MD, MPH

    Yale University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Daniel O'Neil, MD, MPH

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 30, 2025

First Posted

July 23, 2025

Study Start

September 1, 2025

Primary Completion

April 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

November 13, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

In order to comply with local legal requirements, individual participant data will not be available to other researchers.

Locations